Brind.

FDA approved the Genio system for the U.S. market on August 19, 2025, following company reports from Mont-Saint-Guibert and the start of commercial launch.

4 reports, 2 independent Updated Jul 1
Gone quiet Reached 2 outlets in its first 24 hours
Reports
4
Developments
3
Repetition
75%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 2 outlets

FDA approved the Genio system for the U.S. market on August 19, 2025, following company reports from Mont-Saint-Guibert and the start of commercial launch.

Who's involved

What this event is mainly about

How it developed

Newest first. Tap a step to see who reported it.
  1. Hospital in North Alabama introduces the FDA-approved Genio system as a new therapy.Sub-event
  2. FDA approved the Genio system for OSA treatment on August 9, 2025.Sub-event
  3. FDA approved Genio system for U.S. market; company reported from Mont-Saint-Guibert.1 source

Keep exploring

The entities involved

Related events

Coverage

Newest first; wire copies grouped
  • GlobeNewswireNyxoah Reports Second Quarter Financial and Operating Results REGULATED INFORMATION Nyxoah Reports Second Quarter Financial and Operating Results FDA Approves Genio® System for U.S. Market; Company B
  • ZacksNyxoah Secures FDA Clearance for Genio System to Treat Sleep Apnea Nyxoah NYXH recently received FDA approval for its Genio system, an innovative therapy for moderate to severe Obstructive Sleep Apne
  • GlobeNewswireNyxoah Announces Preliminary Results for the Second Quarter of 2025 Nyxoah Announces Preliminary Results for the Second Quarter of 2025 Mont-Saint-Guibert, Belgium – August 11, 2025, 7:00am CET / 1:0
1 more outlet ran the same wire story